Preclinical, Randomized Phase 1, and Compassionate Use Evaluation of REGN4461, a Leptin Receptor Agonist Antibody for Leptin Deficiency.
Judith Y. Altarejos,Jeffrey Pangilinan,Simona Podgrabinska,Baris Akinci,Maria Foss-Freitas,Adam H. Neidert,Yonaton Ray, Wenjun Zheng,Steven Kim,Vishal Kamat, Meilin Huang,Soo Min,Jason Mastaitis,Giselle Dominguez-Gutierrez,Jee-Hae Kim,Panayiotis Stevis,Tammy Huang,Brian Zambrowicz,William C. Olson,Stephen Godin, Elizabeth Bradley, Andrew D. Gewitz, Mark Baker,Rita Hench,Matthew S. Davenport,Thomas L. Chenevert,Frank Dipaola,George D. Yancopoulos,Andrew J. Murphy,Gary A. Herman,Bret J. Musser,Hayes Dansky,Joyce Harp,Jesper Gromada,Mark W. Sleeman,Elif A. Oral,Benjamin A. Olenchock SCIENCE TRANSLATIONAL MEDICINE（2023）
Key words
Leptin,Metabolic Regulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper